Det nye forumet finner du her

Tilbake til: Farma og medisin
Innlegg av: Frontmasta (13.12.17 23:25 ), lest 4639 ganger
Ticker: NANO
Endret: 14.12.17 00:19

NANO. Dose and efficacy study - 80 centres worldwide

Study of Betalutin® for relapsed follicular lymphoma

Part 2 additional 80 patients..


https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/dose-and-efficacy-study-of-betalutin-for-relapsed-follicular-lymphoma/

Tenker at dette er endring av Lymrit 37-06.

EudraCT Number: 2015-001570-17

Sjekk opp folkens, Costa forteller bare det han må........